4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001790340-25-000024
CIK 0001790340other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:10 PM ET
Size
5.4 KB
Accession
0001790340-25-000024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock Option
2025-02-05+480,000→ 480,000 totalExercise: $1.91Exp: 2035-02-05→ Class A Common Stock (480,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:10 PM ET
- Size
- 5.4 KB